Ching-Hsuen Chu
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Lipid metabolism and biosynthesis, Adipose Tissue and Metabolism, Pancreatic function and diabetes, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits(1998)268 cited
- → Microsomal Triglyceride Transfer Protein(1995)159 cited
- → Acyl coenzyme A dependent retinol esterification by acyl coenzyme A:diacylglycerol acyltransferase 1(2005)97 cited
- → 2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors(2007)91 cited
- → Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells(1998)81 cited
- → Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1)(2008)81 cited
- → Backbone and Side Chain Dynamics of Uncomplexed Human Adipocyte and Muscle Fatty Acid-Binding Proteins(1998)79 cited
- → Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases(2021)55 cited
- → Expression, purification, and characterization of human and rat acetyl cfenzyme A carboxylase (ACC) isozymes(2006)53 cited
- → MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity(2022)39 cited